A detailed history of Trilogy Capital Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Trilogy Capital Inc. holds 7,052 shares of MDT stock, worth $678,966. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,052
Previous 6,982 1.0%
Holding current value
$678,966
Previous $608,000 10.36%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$87.67 - $95.74 $6,136 - $6,701
70 Added 1.0%
7,052 $671,000
Q2 2025

Jul 18, 2025

BUY
$80.68 - $88.86 $16,297 - $17,949
202 Added 2.98%
6,982 $608,000
Q1 2025

May 06, 2025

SELL
$79.84 - $94.5 $3,353 - $3,969
-42 Reduced 0.62%
6,780 $609,000
Q4 2024

Jan 27, 2025

BUY
$79.61 - $92.24 $218,131 - $252,737
2,740 Added 67.12%
6,822 $544,000
Q3 2024

Oct 18, 2024

BUY
$76.84 - $91.03 $14,753 - $17,477
192 Added 4.94%
4,082 $367,000
Q2 2024

Jul 22, 2024

BUY
$78.71 - $87.02 $109,800 - $121,392
1,395 Added 55.91%
3,890 $306,000
Q1 2024

Apr 17, 2024

SELL
$82.84 - $88.09 $18,639 - $19,820
-225 Reduced 8.27%
2,495 $217,000
Q4 2023

Jan 11, 2024

BUY
$69.43 - $83.43 $188,849 - $226,929
2,720 New
2,720 $224,000
Q2 2023

Jul 24, 2023

BUY
$79.47 - $91.38 $186,039 - $213,920
2,341 New
2,341 $206,000
Q4 2018

Jan 15, 2019

SELL
$85.8 - $99.49 $15,186 - $17,609
-177 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$85.91 - $99.17 $3,350 - $3,867
39 Added 28.26%
177 $17,000
Q2 2018

Aug 20, 2018

BUY
$77.48 - $87.83 $4,261 - $4,830
55 Added 66.27%
138 $12,000
Q1 2018

May 24, 2018

BUY
$76.55 - $87.26 $6,353 - $7,242
83 New
83 $7,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $128B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Trilogy Capital Inc. Portfolio

Follow Trilogy Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trilogy Capital Inc. with notifications on news.